GoodRx Expands Affordable Access to Cholesterol Drug Repatha

MT Newswires Live
2025/10/06

GoodRx (GDRX) said Monday it is expanding the availability of Amgen's (AMGN) cholesterol drug Repatha at a lower price.

Starting Monday, patients will be able to use GoodRx to buy Repatha for $239 at over 70,000 pharmacies in the US, GoodRx said, adding that the price represents a savings of about 60% off the retail pharmacy list price.

GoodRx shares were up 3.5% in early trading, while Amgen was down 0.5%.

Price: 4.69, Change: +0.16, Percent Change: +3.53

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10